Oncolytics Biotech Inc (ONCY)
1.05
+0.01
(+0.96%)
USD |
NASDAQ |
Apr 23, 14:23
Oncolytics Biotech Shareholders Equity (Quarterly): 20.78M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 20.78M |
September 30, 2023 | 21.35M |
June 30, 2023 | 16.78M |
March 31, 2023 | 19.04M |
December 31, 2022 | 19.53M |
September 30, 2022 | 20.76M |
June 30, 2022 | 23.88M |
March 31, 2022 | 28.05M |
December 31, 2021 | 28.31M |
September 30, 2021 | 33.49M |
June 30, 2021 | 37.49M |
March 31, 2021 | 35.39M |
December 31, 2020 | 19.41M |
September 30, 2020 | 15.67M |
June 30, 2020 | 17.56M |
March 31, 2020 | 16.52M |
December 31, 2019 | -0.0826M |
September 30, 2019 | 2.607M |
June 30, 2019 | 2.885M |
March 31, 2019 | 4.269M |
December 31, 2018 | 4.549M |
September 30, 2018 | 7.004M |
June 30, 2018 | 8.272M |
March 31, 2018 | 3.673M |
December 31, 2017 | 6.588M |
Date | Value |
---|---|
September 30, 2017 | 9.701M |
June 30, 2017 | 10.97M |
March 31, 2017 | 5.455M |
December 31, 2016 | 7.928M |
September 30, 2016 | 11.89M |
June 30, 2016 | 14.37M |
March 31, 2016 | 15.77M |
December 31, 2015 | 17.78M |
September 30, 2015 | 20.65M |
June 30, 2015 | 24.27M |
March 31, 2015 | 21.43M |
December 31, 2014 | 11.90M |
September 30, 2014 | 13.24M |
June 30, 2014 | 15.35M |
March 31, 2014 | 16.47M |
December 31, 2013 | 20.86M |
September 30, 2013 | 26.79M |
June 30, 2013 | 32.29M |
March 31, 2013 | 38.03M |
December 31, 2012 | 14.86M |
September 30, 2012 | 22.81M |
June 30, 2012 | 30.65M |
March 31, 2012 | 41.43M |
December 31, 2011 | 28.92M |
September 30, 2011 | 38.14M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.0826M
Minimum
Dec 2019
37.49M
Maximum
Jun 2021
19.97M
Average
19.53M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
Acasti Pharma Inc | 64.68M |
Aurinia Pharmaceuticals Inc | 377.95M |
Edesa Biotech Inc | 5.845M |
Lexaria Bioscience Corp | 6.521M |
Xenon Pharmaceuticals Inc | 927.92M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 29.26M |
Total Liabilities (Quarterly) | 8.486M |